HGF and cancer: c-Met, a receptor for hepatocyte growth factor (HGF), which is a promoter of cancer progression, has several major alternative downstream pathways in its signaling cascade: Akt 1, 2 and 3 (protein kinase B), signal transducer and activator of transcription 3 (STAT3), and MAPK.